Global Gynecology Drugs Market (2021 to 2030) - Players Include Pfizer, Allergan and AstraZeneca Among Others - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Nov 11, 2021--
The “Gynecology Drugs Global Market Report 2021: COVID-19 Growth and Change” report has been added to ResearchAndMarkets.com’s offering.
This report provides strategists, marketers and senior management with the critical information they need to assess the global gynecology drugs market.
The global gynecology drugs market is expected to grow from $22.22 billion in 2020 to $24.68 billion in 2021 at a compound annual growth rate (CAGR) of 11.07%. The growth is mainly due to the increase in gynecological disorders among women and rising cases of gynecological cancer. The market is expected to reach $31.21 billion in 2025 at a CAGR of 6.05%.
- Hoffmann-La Roche Ltd.
- Pfizer Inc
- Merck & Co. Inc.
- Bayer AG
- TherapeuticsMD Inc
- Lupin Pharmaceuticals Inc.
- Ferring Holding SA
- Johnson & Johnson
- GlaxoSmithKline plc
- Eli Lilly and Company
- Amgen Inc.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
The gynecology drugs market consists of sales of gynecology drugs services by entities (organizations, sole traders, and partnerships) that manufacture gynecology drugs which are used to treat gynecological diseases which includes conditions affecting the uterus, ovaries, and their appendages.
The main types of therapeutics in gynecology drugs are hormonal therapy and non-hormonal therapy. Hormonal therapy is a treatment that adds, blocks or removes hormones to slow or stop the growth of cancer cells that need hormones to grow. Non hormonal therapy involves the usage of anti- infective, anti-inflammatory agents, lubricants, moistures, antidepressants, gabapentin, clonidine and others. Gynecology drugs are used for gynecology cancers, menopausal disorder, polycystic ovary syndrome, contraception and others and distributed through hospital pharmacies, retail pharmacies and online pharmacies.
North America was the largest region in the gynecology drugs market in 2020. Asia Pacific is expected to be the fastest growing region in the forecast period. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Alternative treatment methods and natural remedies are increasingly becoming popular globally which is expected to have a negative impact on the revenues of gynecological drugs companies. Treatments in the fields of homeopathy, Ayurveda, yoga, acupuncture, sujok therapy are gaining popularity and slowly replacing some traditional hospital practices. For instance, Ayurvedic medicine, an ancient Indian system of medicine uses range of techniques and treatments for gynecological cancer. Many of herbs used in Ayurveda have anti-cancer properties, example Curcumin, Holy Basil are said to inhibit the growth of cancerous cells and Ayurvedic gynecological procedures like Agnikarma helps treat cervical erosion. This growing adoption of alternative treatments is expected to have a negative impact on the growth of the market.
Drug manufacturers are investing in developing personalized cancer vaccines, including gynecological cancers, and few have reached clinical trial phases. Pharmaceutical companies are combining genetic sequencing and precision medicine to create new drug therapies and cancer treatments that are designed to treat specific patients.
The countries covered in the gynecology drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.
For more information about this report visit https://www.researchandmarkets.com/r/lywvzc
View source version on businesswire.com:https://www.businesswire.com/news/home/20211111005852/en/
Laura Wood, Senior Press Manager
firstname.lastname@example.orgFor E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH WOMEN CONSUMER OTHER HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2021.
PUB: 11/11/2021 11:02 AM/DISC: 11/11/2021 11:02 AM